Lymphocyte Activation Gene 3 (LAG3) Mouse Monoclonal Antibody [Clone ID: 5F11]

CAT#: TA355131

Mouse Monoclonal Anti-LAG3 Antibody [5F11]



Need it in bulk or conjugated?
Get a free quote

CNY 6,861.00


货期*
5周

规格
    • 100 ug

经常一起买 (2)
beta Actin Mouse Monoclonal Antibody, Clone OTI1, Loading Control
    • 30 ul

CNY 300.00
CNY 1,430.00


Transient overexpression lysate of lymphocyte-activation gene 3 (LAG3)
    • 100 ug

CNY 4,840.00

Specifications

Product Data
Clone Name 5F11
Applications ELISA, FC, IF, IHC, WB
Recommend Dilution ELISA start at 0.25 ug/mL. WB start at 0.25 ug/mL. ICC start at 1 ug/mL. IF start at 10 ug/mL. IHC start at 5 ug/mL. FC start at 1 ug/mL.
Reactivity Human
Host Mouse
Clonality Monoclonal
Immunogen LAG-3 antibody was raised against the extracellular domain of human LAG-3
Formulation LAG-3 Antibody is supplied in PBS containing 0.02% sodium azide.
Concentration 1 mg/ml
Purification LAG-3 Antibody is supplied as protein A purified IgG1.
Conjugation Unconjugated
Storage Condition Store at -20°C as received.
Predicted Protein Size Predicted: 55 kDa; Observed: 60, 70, 80 kDa
Gene Name lymphocyte activating 3
Background The lymphocyte activation gene-3 (LAG3) is a member of the immunoglobulin superfamily and binds MHC class II with high affinity ,negatively regulating T-cell function and homeostasis.It is expressed in B, T, and NK cells, monocytes, and dendritic cells,and acts to regulate T cell expansion.LAG3 is also an important immune checkpoint protein, with anti-LAG3 antibodies activating T effector cells and affecting regulatory T cell functions. Furthermore LAG3 appears to act in a synergistic fashion with PD-1/PD-L1, suggesting that a dual antibody approach may prove useful in cancer immunotherapy.
Synonyms CD223; FDC; LAG-3
Reference Data
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.
Customer Reviews 
Loading...